Skip to main content
. 2016 Nov 29;2016(11):CD012436. doi: 10.1002/14651858.CD012436
Trial Date trial author contacted Date trial author replied Date trial author was asked for additional information
 (short summary) Date trial author provided data
 (short summary)
Atabek 2008 24 January 2014
15 May 2014
No 24 January 2014 ‐ asked for additional unpublished data and other ongoing trials
15 May 2014 ‐ asked for further details about the trial including funding, allocation concealment, randomisation method, dropout rates and adverse events
N/A
Berkowitz 2003 20 January 2014
15 May 2014
No 20 January 2014 ‐ asked for additional unpublished data and other ongoing trials
15 May 2014 ‐ asked for further details about the trial including randomisation method, allocation concealment and adverse events
N/A
Berkowitz 2006 20 January 2014
15 May 2014
No 20 January 2014 ‐ asked for additional unpublished data and other ongoing trials
15 May 2014 ‐ asked for further details on the trial's adverse events
N/A
Chanoine 2005 20 January 2014
25 March 2014
15 May 2014
20 January 2014
25 March 2014
15 May 2014
03/06/2014
20 January 2014 ‐ asked for additional unpublished data and other ongoing trials
25 March 2014 ‐ asked for raw BMI and SD values at 6 months' follow‐up
15 May 2014 ‐ asked for further details about the trial including blinding and adverse events
20 January 2014 ‐ author replied with confirmation the data of the trial was correct and attached an addition paper for the trial
25 March 2014 ‐ author provided the raw data at 6 months
15 May 2014 ‐ provided further details on blinding
3 June 2014 ‐ gave additional results on adverse events
Clarson 2009 24 January 2014
15 May 2014
31 January 2014
19 May 2014
24 January 2014 ‐ asked for additional unpublished data and other ongoing trials
15 May 2014 ‐ asked for further details about the trial including allocation concealment, blinding and adverse events
31 January 2014 ‐ author confirmed there was no further data for the trial and provided a protocol for an ongoing trial
19 May 2014 ‐ author provided further details about the trial
Franco 2014 24 February 2015 9 March 2015 24 February 2015 9 March 2015 ‐ authors replied with further details on the trial such as funding source, randomisation method and blinding
Freemark 2001 20 January 2014
25 March 2014
15 May 2014
16 May 2014 20 January 2014 ‐ asked for additional unpublished data and other ongoing trials
25 March 2014 ‐ asked for BMI raw data and associated SDs
15 May 2014 ‐ asked for further details about the trial including allocation concealment, blinding and adverse events
16 May 2014 ‐ author provided further details about the trial
Garcia‐Morales 2006 21 January 2014
15 May 2014
No 21 January 2014 ‐ asked for additional unpublished data and other ongoing trials
15 May 2014 ‐ asked for further details about the trial including the run‐in period, blinding and adverse events
N/A
Godoy‐Matos 2005 20 January 2014
15 April 2014
17 May 2014 20 January 2014 ‐ asked for additional unpublished data and other ongoing trials
15 April 2014 ‐ asked for further details about the trial including allocation concealment, randomisation method, blinding and adverse events
17 May 2014 ‐ author provided further details about the trial
Kendall 2013 24 January 2014
15 May 2014
29 January 2014 24 January 2014 ‐ asked for additional unpublished data and other ongoing trials
15 May 2014 ‐ asked for further details about the trial including blinding and adverse events
29 January 2014 ‐ author confirmed no additional data were available for the trial
Author did not reply to the follow‐up email (15 May 2014)
Maahs 2006 20 January 2014
09 May 2014
15 May 2014
20 January 2014
09 May 2014
15 May 2014
20 January 2014 ‐ asked for additional unpublished data and other ongoing trials
09 May 2014 ‐ asked to confirmed if the data presented were SDs or SEs
15 May 2014 ‐ asked for further details on the trial's adverse events
20 January 2014 ‐ author confirmed no further data were available for the trial
09 May 2014 ‐ author confirmed the data were SDs
15 May 2014 ‐ author could not provide further information on the adverse events
Mauras 2012 24 January 2014
15 May 2014
16 May 2014
15 May 2014
27 May 2014
24 January 2014 ‐ asked for additional unpublished data and other ongoing trials
15 May 2014 ‐ asked for further details on the trial including allocation concealment, randomisation method, number of trial centres, blinding and adverse events
16 May 2014 ‐ asked for further information on adverse events
15 May 2014 ‐ author provided further details on the trial
27 May 2014 ‐ author said she would try to obtain the data; however, we received no further emails
NCT00001723 30 October 2015 30 October 2015 30 October 2015 ‐ asked for further details on the trial: blinding, allocation concealment, randomisation process, funding, publications and lifestyle programme 30 October 2015 ‐ author replied and gave further details
Ozkan 2004 No ‐ was unable to send emails to the address given in the publication N/A N/A N/A
Prado 2012 17 January 2014
24 January 2014
15 May 2014
28 January 2014
18 May 2014
17 January 2014 ‐ asked for raw BMI data
24 January 2014 ‐ asked for additional unpublished data and other ongoing trials
15 May 2014 ‐ asked for further details on the trial including blinding, allocation concealment and adverse events
28 January 2014 ‐ author was unable to provide any unpublished data
18 May 2014 ‐ author provided further information about the trial
Rezvanian 2010 24 January 2014
15 May 2014
24 January 2014
15 May 2014
24 January 2014 ‐ asked for additional unpublished data and other ongoing trials
15 May 2014 ‐ asked for further details on the trial including allocation concealment and adverse events
24 January 2014 ‐ author confirmed there were no further details to give on the trial and provided references to other potentially relevant trials
15 May 2014 ‐ author provided further details about the trial
Srinivasan 2006 20 January 2014
15 May 2014
15 May 2014 20 January 2014 ‐ asked for additional unpublished data and other ongoing trials
15 May 2014 ‐ asked for further details on the trial including allocation concealment and adverse events
15 May 2014 ‐ author provided further details about the trial
Van Mil 2007 20 January 2014
15 May 2014
20 January 2014
30 May 2014
20 January 2014 ‐ asked for additional unpublished data and other ongoing trials
15 May 2014 ‐ asked for further details on the trial including randomisation, blinding and adverse events
20 January 2014 ‐ author confirmed findings were correct and highlighted the main finding of their trial
30 May 2014 ‐ author provided further details about the trial
Wiegand 2010 24 January 2014
15/04/2014
27 January 2014 24 January 2014 ‐ asked for additional unpublished data and other ongoing trials
15 May 2014 ‐ asked for further details on the trial including allocation concealment, randomisation, blinding and adverse events
27 January 2014 ‐ author confirmed there was no further data available for the trial
Author did not reply to the follow‐up email
Wilson 2010 24 January 2014
15 May 2014
24 January 2014
15 May 2014
24 January 2014 ‐ asked for additional unpublished data and other ongoing trials
15 May 2014 ‐ asked for further details on the trial including dropouts and adverse events
24 January 2014 ‐ author confirmed there was no unpublished data on the main outcomes of the trial
15 May 2014 ‐ author said he would try to obtain the data; however, I did not receive any further emails
Yanovski 2011 24 January 2014
15 May 2014
24 January 2014 24 January 2014 ‐ asked for additional unpublished data and other ongoing trials
15 May 2014 ‐ asked for further details on the trial's adverse events
24 January 2014 ‐ author confirmed the trial was over and there is no further information available
Author did not reply to the follow‐up email
BMI: body mass index; N/A: not applicable; SD: standard deviation; SE: standard error.